NCT05931224View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions
Essential Hypertension
Interventions
DRUG

D064, D702, placebo of D660

Experimental Group Subjects assigned to this group are treated with D064, D702, placebo of D660

DRUG

D660, placebo of D064, placebo of D702

Experimental Group Subjects assigned to this group are treated with D660, placebo of D064, placebo of D702

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY